The cold immunological landscape of ATM-deficient cancers

ATM deficiency, while compromising DNA repair and enhancing sensitivity to radiation and ATR inhibition, does not increase tumor antigenicity or immunogenicity. Altogether, our results have important implications for the design of novel combination therapies for <i>ATM</i> null tumors and highlight the importance of antigenicity in the immunological consequences of defective DNA repair.